Navigation Links
Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA
Date:9/11/2009

GREENSBORO, N.C., Sept. 11 /PRNewswire/ -- Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz's premarket approval (PMA) application for Belotero(R) Balance.

Belotero(R) Balance is a hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology. This application seeks FDA approval for injection into mid-to-deep dermis for correction of moderate to severe wrinkles and folds.

"The FDA's acceptance for review of the Belotero(R) Balance PMA begins the application review process and signifies the beginning of Merz Pharmaceutical's firm footprint in the American aesthetics market," said Jack Britts, president and CEO of Merz Pharmaceuticals, LLC.

"Upon approval, Belotero(R) Balance will be an exciting addition to the dermal filler category," said Dr. Rhoda S. Narins, M.D., the lead investigator for the Belotero(R) clinical trials.

About Belotero(R)

First launched in Germany in 2005, Belotero(R) is also approved for aesthetic use in the United Kingdom, Italy, Russia, Austria and Switzerland.

About Merz Pharmaceuticals

Merz Pharmaceuticals, LLC, a wholly owned, U.S. subsidiary of the Merz Group of Companies was established in 1995 and develops and commercializes prescription products for Neurology, Dermatology, Podiatry and the #1 non-prescription product for scars, Mederma.

With a 101 year heritage, Merz (KGaA) is known worldwide for its development of original compounds and formulations for medical professionals and consumers in 90 countries. Globally, Merz is a leader in the development of pharmaceuticals for the treatment of neurological and psychological disorders as well as for aesthetic medicine, including products
'/>"/>

SOURCE Merz Pharmaceuticals, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
2. Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
3. Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
4. Reportlinker Adds US and European Radiopharmaceuticals Market Report
5. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
6. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
7. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
8. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
11. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 Today the Brain ... Awareness Month, a time to recognize and support the more ... , Each year BIAA leads the nation in observing ... the month of March. The theme for the 2015 to ... campaign provides a platform for educating the general public about ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to ... Industry Analysts Inc and recently added to its catalogue. ... Through 2018, the global radiation therapy equipment market is ... report suggests a holistic analysis of the situation in ... as covers the top market trends. The publication uncovers ...
(Date:3/2/2015)... 2015 Tyrone Christopher, Co-founder of Soft ... for the model agency industry, have launched Softcandy.sexy, an ... Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla flavored ... , At a cost of alienating a few potential ... by announcing the brands commitment and support of a ...
(Date:3/2/2015)... March 02, 2015 After a rigorous ... customer service, pricing and long-term strategy, Blood Centers of ... of choice for member centers’ testing needs. , BCA, ... represents more than 30 percent of the U.S. blood ... , “BCA is committed to drive cost savings to ...
(Date:3/2/2015)... Mountain View, CA (PRWEB) March 02, 2015 ... announced today that it has officially launched a ... Bo Gustafsson, head of product development for BNatrl, ... developed through feedback from Olympic and other world-class ... I'm excited to use this pure whole food ...
Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Aug. 31 ... uses a virus to infect and destroy tumor cells without ... The small, Phase 1 trial involved 23 patients with ... had exhausted other treatment options. Each received an intravenous ...
... HealthDay Reporter , WEDNESDAY, Aug. 31 (HealthDay News) ... their calories from sweetened drinks, a new report indicates. ... sugar in one,s diet, and for many, sugar-sweetened drinks are ... to obesity and related illnesses such as diabetes, experts say. ...
... August 31, 2011 - Scientists at The Scripps Research ... a direct role in the development and spread of cancerous ... the disease and points toward novel strategies for treating early-stage ... issue of the American Journal of Pathology . ...
... Aug. 31 (HealthDay News) -- A new study says physical ... for patients with melanoma, the most dangerous form of skin ... found that young melanoma patients in poor health had worse ... study of 101 patients treated for stage III melanoma showed ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- Smoking causes more arterial ... Researchers used ultrasound to assess the carotid arteries (neck ... and 1,694 men in Finland, Sweden, the Netherlands, France and ... was associated with thickening of the arterial walls (atherosclerosis) in ...
... , WEDNESDAY, Aug. 31 (HealthDay News) --,Hospitalized ... but show no signs of illness are still at ... finds. The germ -- methicillin-resistant staphylococcus aureus (MRSA) ... year in the United States. Johns Hopkins Children,s ...
Cached Medicine News:Health News:Trial of Cancer-Fighting Virus Shows Promise 2Health News:Trial of Cancer-Fighting Virus Shows Promise 3Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 2Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 3Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 4Health News:Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer 2Health News:Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer 3Health News:Kids Carrying MRSA Germ Prone to Serious Infection: Study 2
(Date:3/2/2015)...  Intrexon Corporation (NYSE: XON ), ... fourth quarter and full year results for 2014.  ... , Acquired ActoGeniX, a European clinical stage ... therapeutics and other innovative products.  Its proprietary TopAct™ ... ( Lactococcus lactis ) to generate biologically-contained ActoBiotics™ ...
(Date:3/2/2015)... , March 2, 2015 BD (Becton, ... leading global medical technology company, today announced the acquisition ... -based medical technology company dedicated to improving the ... furthers BD,s position in helping address preventable medication errors ... CRISI entered into an exclusive partnership in June 2013 ...
(Date:3/2/2015)... 2015   Oriel STAT A MATRIX ... the most critical compliance and performance issues in ... manufacturers are experiencing an industry-transforming level of demand ... and global supply chains are negatively impacting product ... global regulators are increasing compliance requirements, scrutiny, and ...
Breaking Medicine Technology:Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 2Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 3
... Israel, Nov. 15, 2011 InspireMD, Inc. (OTC ... focusing on the development and commercialization of its proprietary stent ... 10-Q for the three months ended September 30, 2011 with ... update on progress year-to-date: Year-to-Date Highlights ...
... to Quit" is a comprehensive quit-smoking program designed ... available exclusively at Walmart. Through the program, smokers ... QuitNet.com – including trained experts and a variety ... nicotine replacement therapy (NRT) to help curb cravings ...
Cached Medicine Technology:InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 2InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 3InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 4InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 5InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 6InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 7InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 8InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 9New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 2New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 3New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: